Zobrazeno 1 - 10
of 209
pro vyhledávání: '"M. Nijenhuis"'
Autor:
Bernard A Fox, Rieneke van de Ven, Carmen Ballesteros-Merino, Tara Muijlwijk, Sonja H Ganzevles, Ruud H Brakenhoff, Jos B Poell, Dennis N L M Nijenhuis, C René Leemans, Laura A N Peferoen, Elisabeth Bloemena, Fatima Ekhlas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Approximately 50% of head and neck squamous cell carcinomas (HNSCC) recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options for recurrent/metastatic HNSCC; however, less than 20% of patients respond.
Externí odkaz:
https://doaj.org/article/706241e19a784c6ebfc691493690aafb
Autor:
Bernard A Fox, Rieneke van de Ven, Yoshinobu Koguchi, Venkatesh Rajamanickam, Tara Muijlwijk, Sonja H Ganzevles, Ruud H Brakenhoff, Arjen Brink, Changlin Ke, Joseph N Fass, Jos B Poell, Dennis N L M Nijenhuis, C René Leemans
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background The response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Detailed understanding of the tumor i
Externí odkaz:
https://doaj.org/article/4c0703b158e44abebdb94f559e449d18
Autor:
Stefanie L. Groenland, J. M. Janssen, C. M. Nijenhuis, N. de Vries, H. Rosing, S. Wilgenhof, J. V. van Thienen, J. B. A. G. Haanen, C. U. Blank, J. H. Beijnen, A. D. R. Huitema, N. Steeghs
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:447-456
Autor:
Niels E. Wondergem, Dennis N. L. M. Nijenhuis, Jos B. Poell, C. René Leemans, Ruud H. Brakenhoff, Rieneke van de Ven
Publikováno v:
Frontiers in Oral Health, Vol 2 (2021)
Background: Recent advances in immunotherapy for head and neck squamous cell carcinoma (HNSCC) have led to implementation of anti-programmed death receptor 1 (PD-1) immunotherapy to standard of care for recurrent/metastatic HNSCC. However, the majori
Externí odkaz:
https://doaj.org/article/f98288047e844af49060e0428d38ea76
Autor:
Mathilde C. S. C. Vermeer, Daniela Andrei, Duco Kramer, Albertine M. Nijenhuis, Yvonne M. Hoedemaekers, Helga Westers, Jan D. H. Jongbloed, Hendri H. Pas, Maarten P. van den Berg, Herman H. W. Silljé, Peter van der Meer, Maria C. Bolling
Publikováno v:
Experimental dermatology, 31(6), 970-979. Blackwell Publishing Ltd
Desmoplakin (DP) is an important component of desmosomes, essential in cell-cell connecting structures in stress-bearing tissues. Over many hundreds of pathogenic variants in DSP have been associated with different cutaneous and cardiac phenotypes or
Publikováno v:
IFAC-PapersOnLine. 55:166-171
Flexure mechanisms are widely used in precision applications. The finite support stiffness results in parasitic resonance frequencies, typically with low damping, that can be detrimental for positioning performance. Moreover, these resonances may var
Autor:
Federica Giurdanella, Albertine M. Nijenhuis, Gilles F. H. Diercks, Marcel F. Jonkman, Hendri H. Pas
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The serological diagnosis of pemphigus relies on the detection of IgG autoantibodies directed against the epithelial cell surface by indirect immunofluorescence (IIF) on monkey esophagus and against desmoglein 1 (Dsg1) and Dsg3 by ELISA. Although bei
Externí odkaz:
https://doaj.org/article/fae57984601c4b56b45d2a816a215eda
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tom H van de Belt, Gijs Hesselink, Harry van Goor, Merlijn Smits, Sharon M. Nijenhuis, Mariël Doedens, Denise van Bavel
Publikováno v:
HERD, 13, 125-139
Herd
HERD, 13, 3, pp. 125-139
Herd
HERD, 13, 3, pp. 125-139
Objectives: Gaining an understanding of postoperative patients’ environmental needs, barriers, and facilitators for optimal healing. Background: An optimal hospital environment (the “healing environment”) can enhance patients’ postoperative r